Antiplatelet Therapy in Coronary Artery Disease: A Daunting Dilemma

Antiplatelet Therapy in Coronary Artery Disease: A Daunting Dilemma

Percutaneous coronary intervention (PCI) with stenting for the treatment of acute coronary syndrome (ACS) is the contemporary standard of care. Such treatment is followed by dual antiplatelet therapy (DAPT) comprising of aspirin and a P2Y12 inhibitor. The efficacy of this therapy has been well estab...

Full description

Bibliographic Details
Main Authors:	Surya Chaturvedula, Daniel Diver, Aseem Vashist
Format:	Article
Language:	English
Published:	MDPI AG 2018-04-01
Series:	Journal of Clinical Medicine
Subjects:	dual antiplatelet therapy coronary artery disease acute coronary syndrome drug eluting stent bare metal stent aspirin clopidogrel prasugrel ticagrelor triple therapy oral anticoagulants
Online Access:	http://www.mdpi.com/2077-0383/7/4/74

Similar Items

Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysis
by: Xiaojun Zhuo, et al.
Published: (2018-09-01)

Dual Antiplatelet Therapy in Coronary Artery Disease
by: Raghav Sharma, et al.
Published: (2020-08-01)

Double antiplatelet therapy in patients with acute coronary syndrome
by: A. V. Rodionov, et al.
Published: (2011-10-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
by: A. N. Golosova, et al.
Published: (2020-08-01)

Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice?
by: T. M. Uskach, et al.
Published: (2020-12-01)

Comparison of ESC and ACCF/AHA Guidelines for Oral Antiplatelet Treatment in the Management of Patients with Acute Coronary Syndrome
by: Ayhan Sarıtaş, et al.
Published: (2016-09-01)

Efficacy and safety of antiplatelet drugs in patients with chronic kidney disease
by: İbrahim Yıldız, et al.
Published: (2014-07-01)

Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials
by: Mahmoud Barbarawi, et al.
Published: (2019-01-01)

Clopidogrel in the treatment of patients with ST-elevation acute myocardial infarction: state-of-art in 2013
by: O. V. Averkov
Published: (2013-02-01)

Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents
by: Ying Shen, et al.
Published: (2015-01-01)

A cost-effectiveness and safety analysis of dual antiplatelet therapy comparing aspirin–clopidogrel to aspirin–ticagrelor in patients with acute coronary syndrome
by: Nafrialdi Nafrialdi, et al.
Published: (2018-12-01)

Vorapaxar
by: Gianluca Airoldi, et al.
Published: (2013-04-01)

Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk
by: O. V. Averkov
Published: (2021-02-01)

Ticagrelor
by: Gianluca Airoldi, et al.
Published: (2013-03-01)

Antiplatelet Therapy in a Patient with Coronary Artery Disease and Myelodysplastic Syndrome with Thrombocytopenia
by: Francisco José Fernández-Fernández, et al.
Published: (2017-10-01)

Antithrombotic Therapy in Patients with Coronary Artery Disease and Prior Stroke
by: Elisa Bellettini, et al.
Published: (2021-04-01)

Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study
by: Hua Yan, et al.
Published: (2020-06-01)

Can antiplatelet therapy after drug eluting stent become a problem?
by: Michele Romano
Published: (2009-03-01)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
by: Viviana Laredo, et al.
Published: (2020-05-01)

Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events
by: Leonardo De Luca, et al.
Published: (2021-04-01)

Platelet inhibition during ticagrelor monotherapy versus ticagrelor plus aspirin in patients with coronary artery disease (TEMPLATE study): study protocol for a randomised controlled trial
by: Sarah Baos, et al.
Published: (2017-11-01)

Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective
by: Gregorio Tersalvi, et al.
Published: (2020-07-01)

Antithrombotic treatments for patients with atrial fibrillation and a requirement for a coronary artery stent
by: Andrew.Owen
Published: (2013-01-01)

ANTIPLATELET THERAPY OF ACUTE CORONARY SYNDROME: CURRENT CAPAB ILITIES
by: E. V. Konstantinova, et al.
Published: (2018-07-01)

DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE
by: G. N. Guseva, et al.
Published: (2015-09-01)

Oral antiplatelet therapy and platelet inhibition: An experience from a tertiary care center
by: Jamshed J. Dalal, et al.
Published: (2016-09-01)

Arterial switch operation for transposition of great arteries: late results in adult patients
by: Giancarlo Scognamiglio, et al.
Published: (2013-01-01)

Left atrial strain rate estimates PCWP
by: Mark Henein, et al.
Published: (2013-01-01)

Stent thrombosis associated with drug eluting stents on addition of cilostazol to the standard dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis of published randomized controlled trials
by: Feng Huang
Published: (2018-06-01)

Antiplatelet Therapy in the Patient with Coronary Stent Undergoing Surgery and Dental Procedure
by: Noppadol Chamnarnphol
Published: (2011-04-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

Clopidogrel resistance: The way forward
by: Shuvanan Ray
Published: (2014-09-01)

What is the Optimal Duration of Dual Antiplatelet Therapy After Stenting?
by: Udaya S. Tantry, PhD, et al.
Published: (2016-05-01)

Prasugrel
by: Gianluca Airoldi, et al.
Published: (2013-04-01)

The choice of the P2Y12 receptors blocker in the treatment of a patient with acute coronary syndrome: practice of N.I. Pirogov city clinical hospital №1
by: M. R. Atabegashvili, et al.
Published: (2019-04-01)

OPTIMA Tacrolimus-eluting Stent: A Twelve-month Clinical Follow up with Two Different Periods of Dual Antiplatelet Therapy; 2-monthvs. 6-month Approach
by: Nasser Aslanabadi, et al.
Published: (2012-09-01)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
by: Jianyu Qu, et al.
Published: (2021-06-01)

Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention
by: Mshelbwala FS, et al.
Published: (2020-04-01)

Clinical Outcomes of Very Short Term Dual Antiplatelet Therapy in Patients With or Without Diabetes Undergoing Second-Generation Drug-Eluting Stents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
by: Xi-Ying Liang, et al.
Published: (2021-07-01)

Clopidogrel or ticagrelor alongside dabigatran in acute coronary syndrome and indication for NOAC: A study rationale
by: Luijkx, J., et al.
Published: (2022)